CV Sciences Inc (CVSI)

[Thomas@yahoo]

💥🚀Some Highlights of Q2 2025 Earnings Call Transcript: “We continue to maintain our number one position in the natural product retail channel, and we have also increased our market share in this important sales channel as well. During Q2, we continued our efforts to grow our revenue base with fully diversified product offering’s, which will include more non cannabinoid products. We are launching several NEW non cannabinoid products in late 2025.”
“We are also looking for more revenue growth through our M&A strategy and are beginning to realize some of the early benefits from our acquisition of Elevated Softgels, especially with in source manufacturing of many of our products previously produced by contract manufacturers.”
“Next, I want to reemphasize the goals of our M&A strategy, which are primarily to increase our scale leading to greater revenue, but also to increase our cost efficiency. We are looking for opportunities to increase revenue profitably with transactions that can leverage our operating platform, brands, and distribution.”
“Our most recent transaction of Elevated Softgels provides us with an immediate opportunity to in source manufacturing of a significant number of our products. We are already realizing efficiency gains and expect to see greater cost efficiency and gross margin improvement in 2025 directly from the integration of Elevated Softgels.
“We are also expanding the manufacturing capability of our Elevated Softgels facility and are investing in equipment and people to achieve this goal.”
“Our investment in Cultured Foods achieved an exciting milestone during 2025 with the launch 🚀 of Lunar Fox Foods 🦊, an all new line of plant-based foods offering vegetarian friendly nutrition alternatives for our customers. Lunar Fox 🦊 products are a 💯% natural, gluten free, and respond to growing demand for vegan products, a fast growing category driven by consumers seeking alternative health conscious products.”
“Lunar Fox 🦊 products are now available at select retailers and from the company’s new website @ lunarfoxfoods.com

“We will continue to use our strong operating platform to utilize our M&A strategy, to acquire assets that add revenue, increase our scale, and provide operational leverage and efficiency. We will continue to evaluate inbound and outbound M&A opportunities that support our strategic plan of achieving these goals. We are making good progress as shown by our Q2 2025 results.
“Our M&A strategy will continue and is focused on BOTh large and small complementary consumer product companies that will add revenue and allow for operating synergy to increase sales and profitability.”
“We also continue to look at M&A opportunities to further in source manufacturing to achieve operating leverage through greater scale, leading to a company that can achieve strong profitability and shareholder value.”

💥🌱 https://www.investing.com/news/transcripts/earnings-call-transcript-cv-sciences-sees-highest-gross-margin-since-2019-in-q2-2025-93CH-4190173 🚀💰


💥 🌱 https://www.marijuanamoment.net/medical-marijuana-effectively-treats-pain-with-terpenoids-being-more-influential-than-thc-or-cbd-study-shows/ 🪴

💥 https://onlinelibrary.wiley.com/doi/10.1111/epi.18496 🌱